Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04172207
Other study ID # Istanbul Medipol University
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 15, 2018
Est. completion date September 15, 2019

Study information

Verified date November 2019
Source Istanbul Medipol University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Antimicrobial or antibiotic agents, which are essential to prevent and treat bacterial infectious diseases, have become one of the most widely used drugs in the world. In the European region, the highest rates of antibiotic consumption are reported in Turkey. There is a nearly fivefold difference between Turkey and the lowest consuming countries.

Studies in dentistry evaluate participants according to the basis of predefined criteria. History of antibiotic consumption is one of the most common exclusion criteria for periodontal trials. However, there is still disagreement on how long the effect of systemic antibiotic agents on the oral mucosa and periodontal tissue lasts. It is unclear whether the timing of antibiotic consumption should be an exclusion criterion for genetic damage and histological studies during the selection of healthy participants.

Periodontal status of participants in study groups is described as with or without periodontitis in many studies, because of the lack of clear definitions of periodontal health and gingivitis. It should be recognized that even the lack of visual signs of inflammation, some mild histopathological changes can be seen in the periodontium. Consequently, for the real diagnosis of the clinically healthy periodontium, clinical findings should be supported and confirmed with histological results.

Micronuclei (Mn) are observed as abnormal nuclear structures and indicators of chromosomal level DNA damage. The oral mucosa epithelium is an immunologic barrier and affected by chemical factors such as antibiotic consumption. The Mn test to exfoliated epithelial cells from the oral cavity is utilized as a non-invasive diagnostic technique for monitoring the status of oral health. To our knowledge, no studies have been conducted on the comparison of the impacts of the timing of antibiotic consumption on human periodontal tissues and oral smear samples. The present study is undertaken to determine whether the different timing of antibiotic (amoxicillin) therapy has effects on the histopathology of gingiva and genetic damage of exfoliated cells from oral mucosa in healthy participants.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date September 15, 2019
Est. primary completion date June 15, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Systemically and periodontally healthy participants

- Presence of probing depth (PD) of = 3 mm14 and bleeding on probing (BOP) ? 10%15

- No clinical evidence of gingival recession (GR), clinic attachment loss or radiographic evidence of alveolar bone loss

- No periodontal treatment within the last 12 months

Exclusion Criteria:

- Smoking, alcohol or drug abuse

- Any systemic condition would affect the periodontal health (i.e., pregnancy, lactation, ovulation, and diabetes mellitus)

- A history of contagious disease

- Periodontal treatment within the last 12 months

Study Design


Intervention

Other:
Sampling
After periodontal parameters measured, smear samples were obtained from the buccal mucosa and keratinized gingiva, and then a gingival biopsy was performed from the upper premolars.

Locations

Country Name City State
Turkey Begum Alkan Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Istanbul Medipol University Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effects of antibiotics on gingiva confirmed by histopathology. Modified histological criteria was the measurement used for the semi-quantitative histological assessment of gingival damage. Cellular components, vascularization, cell infiltration, necrosis, pyknotic nucleus, hyperemia, fibrosis, ulceration, atrophy, apoptosis, and rete peg configuration were scored by using a scale ranging from 0 to 3 (none : 0, mild: 1, moderate: 2, and severe : 3) for each criterion. 1-week
Primary Effects of antibiotics on buccal and oral smear confirmed by quantitative determination of the micronuclei. The method has been applied both for monitoring chromosome damage and/or proteins may also result in unsuccessful attachment of a whole chromosome at anaphase stage which subsequently also gives rise to a micronucleus. Thus, quantitative determination of the micronuclei are unique amongst cytogenetic tests in that it provides a reliable measure of both chromosome loss and breakage. 1-week
See also
  Status Clinical Trial Phase
Recruiting NCT05846399 - CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE) Phase 4
Completed NCT03349567 - Improving Antimicrobial-Prescribing in Emergency Departments N/A
Completed NCT05261152 - S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections Phase 4
Terminated NCT03089697 - Phase IIa Clinical Study of N-Rephasin® SAL200 Phase 2
Completed NCT03037112 - Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse N/A
Recruiting NCT03440216 - Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units N/A
Completed NCT03408457 - Influence of Perioperative Fluid Balance on Serum Concentrations of Antibiotics and Surgical Site Infections
Completed NCT04872400 - Acute Application of Antibiotic Powder in Open Fracture Wounds Phase 4
Completed NCT03114358 - Carbapenems De-escalation as Antimicrobial Stewardship N/A
Completed NCT03245879 - Antibiotic Stewardship in Small Hospitals N/A
Recruiting NCT05925309 - Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy N/A
Completed NCT03098485 - Healthy Patients & Effect of Antibiotics N/A
Completed NCT00272155 - An Intervention to Reduce Inappropriate Prescriptions of Antibiotics for Respiratory Infections in General Practice Phase 1/Phase 2
Completed NCT03280147 - 7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis Phase 3
Completed NCT04713436 - The Effects of Antibiotic Combinations on Stem Cells
Completed NCT03446053 - A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers Phase 1
Completed NCT04210713 - Neuroimmune Dysfunction in Alcohol Use Disorder Phase 1
Recruiting NCT05132829 - Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial Phase 4
Recruiting NCT05284318 - Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI.
Completed NCT01855048 - A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers Phase 1